Forte Biosciences (FBRX) Stock Statistics & Valuation Metrics

Forte Biosciences has a market cap or net worth of $430.67M. The enterprise value is $186.03M.

Forte Biosciences has 20,478,817 shares outstanding. The number of shares has decreased by -2.65% in one year.

Forte Biosciences’s return on equity (ROE) is -1.14 and return on invested capital (ROIC) is -113.91%.

The current PE Ratio of Forte Biosciences is ―. Forte Biosciences’s PEG ratio is 0.09.

In the last 12 months, Forte Biosciences had revenue of 0.00 and earned -69.38M in profits. Earnings per share was -4.71.

In the last 12 months, operating cash flow was -50.88M and capital expenditures -116.00K, giving a free cash flow of -51.00M billion.

Forte Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Forte Biosciences upcoming earnings date is Aug 17, 2026, After Close (Confirmed).

Forte Biosciences as a current ratio of 3.88, with Debt / Equity ratio of ―

In the past 12 months, Forte Biosciences has paid 1.04M in taxes.

Forte Biosciences EV to EBITDA ratio is -57.66, with an EV/FCF ratio of -77.19.

Forte Biosciences has $76.96M in cash and marketable securities with $0.00 in debt, giving a net cash position of $76.96M billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Forte Biosciences is $67.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy